You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

Not yet recruiting
  • Refractory
  • +2 more
  • GTP regimen
  • (no location specified)
Sep 8, 2023

OR Regimen Refractory Marginal Zone Lymphoma Trial (obrutinib, rituximab)

Not yet recruiting
  • OR Regimen Refractory Marginal Zone Lymphoma
  • obrutinib, rituximab
  • (no location specified)
Nov 12, 2023

Refractory Status Epilepticus Trial in France (Isoflurane)

Not yet recruiting
  • Refractory Status Epilepticus
  • Beuvry, France
  • +3 more
Apr 13, 2023

Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))

Not yet recruiting
  • Refractory Cancer
  • Relapsed Cancer
  • Drug Sensitivity Test (DST)
  • Weston, Florida
    Lerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023

Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

Not yet recruiting
  • Meningioma
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 21, 2023

Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Refractory Metastatic Colorectal Cancer
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Aug 3, 2023

Refractory Atlantoaxial Dislocation, Surgical Strategies Trial (Anterior oral release+posterior fixation fusion)

Not yet recruiting
  • Refractory Atlantoaxial Dislocation; Surgical Strategies
  • Anterior oral release+posterior fixation fusion
  • (no location specified)
Apr 26, 2023

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Intravitreal Dexamethasone Implant for Refractory Diabetic

Completed
  • Diabetic Macular Edema
  • Intravitreal Dexamethasone Implant for refractory Diabetic macular edema:
  • Cairo, Egypt
    Kasr alainy faculty of medicine
May 5, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

    Not yet recruiting
    • Relapsed and/or Refractory Multiple Myeloma
    • Köln, Germany
      Local Institution - 0017
    Dec 4, 2023

    Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

    Recruiting
    • Refractory Solid Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Precision Medicine Treatment for Refractory Solid Tumors

    Recruiting
    • Refractory Solid Tumors
    • Next Generation Sequencing
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Sep 2, 2023

      Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
      • (no location specified)
      Sep 5, 2023

      Status Epilepticus, Refractory Status Epilepticus Trial in New Haven (Transcranial Direct Current Stimulation)

      Not yet recruiting
      • Status Epilepticus
      • Refractory Status Epilepticus
      • Transcranial Direct Current Stimulation
      • New Haven, Connecticut
        Yale New Haven Hospital
      Jun 28, 2023

      PET-CT Imaging in Relapsed/Refractory Acute Leukemias

      Not yet recruiting
      • B Cell
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 4, 2023

        Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

        Not yet recruiting
        • Relapsed/Refractory Multiple Myeloma
        • Suzhou, Jiangsu, China
          First Affiliated Hospital, Soochow University
        Jul 31, 2023

        Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Acute Myeloid Leukemia, in Relapse
        • anti Tim-3/CD123 CAR-T cell therapy
        • Xuzhou, Jiangsu, China
          Kailin Xu
        Nov 4, 2023

        Relapsed/Refractory B-Cell Lymphoma Trial (FT522, Rituximab, Cyclophosphamide)

        Not yet recruiting
        • Relapsed/Refractory B-Cell Lymphoma
        • (no location specified)
        Jul 10, 2023

        Refractory Focal Epilepsy Trial in Beijing (iPSC-Exos)

        Recruiting
        • Refractory Focal Epilepsy
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jun 5, 2023

        Dermatitis Herpetiformis Trial in Tampere (Assessment of prognosis of refractory dermatitis herpetiformis. No intervention)

        Enrolling by invitation
        • Dermatitis Herpetiformis
        • Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
        • Tampere, Finland
          Tampere University Hospital
        Aug 18, 2023

        Cryoablation for Advanced and Refractory Desmoid Tumors

        Recruiting
        • Desmoid Tumors
          • Strasbourg, France
            Service d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
          Oct 30, 2023

          Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

          Not yet recruiting
          • Relapsed or Refractory Multiple Myeloma
          • (no location specified)
          Sep 20, 2023